Literature DB >> 3177919

Pharmacokinetics of lidocaine and bupivacaine following subarachnoid administration in surgical patients: simultaneous investigation of absorption and disposition kinetics using stable isotopes.

A G Burm1, J W Van Kleef, N P Vermeulen, G Olthof, D D Breimer, J Spierdijk.   

Abstract

The pharmacokinetics of lidocaine and bupivacaine following subarachnoid administration were studied in 12 surgical patients using a stable isotope method. After subarachnoid administration of the agent to be evaluated, a deuterium-labelled analogue was administered intravenously. Blood samples were collected for 24 h. Plasma concentrations of the unlabelled and the deuterium-labelled local anesthetics were determined using a combination of capillary gas chromatography and mass fragmentography. Bi-exponential functions were fitted to the plasma concentration-time data of the deuterium-labelled local anesthetics. The progression of the absorption was evaluated using deconvolution. Mono- and bi-exponential functions were then fitted to the fraction absorbed versus time data. The distribution and elimination half-lives of the deuterium-labelled analogues were 25 +/- 13 min (mean +/- SD) and 121 +/- 31 min for lidocaine and 19 +/- 10 min and 131 +/- 33 min for bupivacaine. The volumes of the central compartment and steady-state volumes of distribution were: lidocaine 57 +/- 10 l and 105 +/- 25 l, bupivacaine 25 +/- 6 l and 63 +/- 22 l. Total plasma clearance values averaged 0.97 +/- 0.21 l/min for lidocaine and 0.56 +/- 0.14 l/min for bupivacaine. The absorption of lidocaine could be described by a single first order absorption process, characterized by a half-life of 71 +/- 17 min in five out of six patients. The absorption of bupivacaine could be described adequately assuming two parallel first order absorption processes in all six patients. The half-lives, characterizing the fast and slow absorption processes of bupivacaine, were 50 +/- 27 min and 408 +/- 275 min, respectively. The fractions of the dose, absorbed in the fast and slow processes, were 0.35 +/- 0.17 and 0.61 +/- 0.16, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177919     DOI: 10.1097/00000542-198810000-00020

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  The effect of age on the systemic absorption, disposition and pharmacodynamics of bupivacaine after epidural administration.

Authors:  B T Veering; A G Burm; A A Vletter; R P van den Heuvel; W Onkenhout; J Spierdijk
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

2.  Accidental total subarachnoid block following local scalp anesthesia.

Authors:  F Yanagi; T Kano
Journal:  J Anesth       Date:  1996-03       Impact factor: 2.078

3.  A population pharmacokinetic model for the complex systemic absorption of ropivacaine after femoral nerve block in patients undergoing knee surgery.

Authors:  François Gaudreault; Pierre Drolet; Michel Fallaha; France Varin
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-09-30       Impact factor: 2.745

Review 4.  Regional anaesthesia in the elderly: a clinical guide.

Authors:  Ban C H Tsui; Alese Wagner; Brendan Finucane
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

5.  Pharmacokinetics of bupivacaine enantiomers in sheep: influence of dosage regimen and study design.

Authors:  L E Mather; A J Rutten; J L Plummer
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

Review 6.  Clinical pharmacokinetics of epidural and spinal anaesthesia.

Authors:  A G Burm
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

7.  The analgesic efficacy of intravenous lidocaine infusion after laparoscopic fundoplication: a prospective, randomized, double-blind, placebo-controlled trial.

Authors:  Gregory J Dale; Stephanie Phillips; Gregory L Falk
Journal:  Local Reg Anesth       Date:  2016-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.